Kairos Pharma Ltd. (KAPA)
Market Closed
10 Aug, 20:00
AMEX AMEX Primary $
0. 35
-0.04
-9.3264%
$
8.35M Market Cap
- P/E Ratio
- Div Yield
862,187 Volume
0 Eps
$ 0.39
Previous Close Want to track KAPA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kairos Pharma Ltd. (KAPA) Statistics
Valuation metrics
Market Cap 8.35M
Enterprise value 4.59M
Trailing P/E (ttm) -1.29
Forward P/E -
PEG ratio 0.09
Price/Sales (ttm) -
Price/Book (mrq) 1.53
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.02M
Average volume (90 days) 1.7M
Price summary
52-Week low 0.27
52-Week high 2.11
Beta -
50-Day moving average 0.35
200-Day moving average 0.52
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.02%
Return on equity -0.92%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.17
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 10.31%
Book value per share (mrq) 0.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
